# US 9,518,984 B2 · Separation, washing and determination of analytes tagged with magnetic particles > Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt - Number: US 9,518,984 B2 - Document ID: US9518984B2 - Status: Granted - Kind: B2 - Application number: 13/385,427 - Filed: 2012-02-21 - Published: 2012-08-23 - Granted: 2016-12-13 - Earliest claimed: 2011-02-22 - Assignees: Chrome Red Technologies, LLC - Applicants: Henry A. Graham; John G. Gorman; James P. Rowell - Inventors: Henry A. Graham; John G. Gorman; James P. Rowell - Web page: https://patentgrep.com/patent/US9518984B2 ## CPC - G01N 33/54326: {Magnetic particles} - G01N 33/80: involving blood groups or blood types {or red blood cells (white blood cells G01N33/56972)} - G01N 2446/00: Magnetic particle immunoreagent carriers - G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q) ## Abstract Method for detecting a material of interest, usually an antibody or an antigen on a red blood cell, in a liquid, by observing the potential antigen/antibody reaction products in a novel way. Reaction products are deposited on a magnetic substrate and will exhibit different properties depending upon whether or not the antigen/antibody reaction has taken place. An antigen/antibody reaction product adheres tenaciously to itself and the substrate while the deposit of any unreacted magnetically tagged material is weakly adhering and easily disrupted and dislodged under a disruptive force which would be insufficient to dislodge the reacted deposit. This difference in cohesive property provides the means by which a positive result is distinguished from a negative result. ## Claims ### Claim 1 A method for determining the presence of a material of interest (MOI) in a sample, in which the MOI is, a). a blood group antigen present on a red blood cell, in said sample, or b). an antibody in said sample that binds to a blood group antigen present on a red blood cell, which method comprises, A. preparing a reaction mixture of a) or b) with a binding partner for the MOI whose presence is sought to be determined, said, binding partner, in the case when the MOI is as described in a), being an antibody which binds with the red blood cell group antigen of a) above, or, in the case where the MOI is an antibody as described in b) above, said binding partner of the MOI being the blood group antigen present on a red blood cell as described in b) above, wherein said red blood cells are either directly tagged with magnetic particles or indirectly tagged through a linkage to the red blood cell with a red blood cell binding agent such as a lectin tagged with magnetic particles, whereby the magnetically tagged red blood cell particles react with the MOI if present to produce a reacted magnetic particle/MOI complex, or do not so react if the MOI is not present and remain as unreacted magnetically tagged red blood cell particles, B. providing a capture vessel comprising a paramagnetic capture element, and a wash fluid which optionally comprises an anti-species globulin such as Coombs serum, either in the fluid or on the element or both, C. introducing the reaction product mixture of step A into the capture vessel of step B, D. applying a magnetic force to the paramagnetic capture element whereby the paramagnetic capture element is rendered magnetic by said magnetic force, and the reacted magnetically tagged particles/MOI complex and any unreacted magnetically tagged red blood cell particles from the reaction mixture are moved into and through the wash fluid, E. allowing the magnetically tagged particles to form a deposit on the paramagnetic capture element and thereafter discontinuing application of the magnetic force after deposition occurs, F. applying a disruptive force to the deposit on the paramagnetic capture element to determine if the deposit is a strongly adhering deposit or large agglutinate, combined with or without anti-species globulin, thus indicating a positive result for the presence of the MOI, or a weakly adhering blood cell antigen deposit thus indicating a negative result for the presence of the MOI. ### Claim 2 (depends on 1) The method according to claim 1 wherein the material of interest is a). blood group antigen present on a red blood cell. ### Claim 3 (depends on 1) The method according to claim 1 wherein the material of interest is b) an antibody that binds to a blood group antigen present on a red blood cell. ### Claim 4 (depends on 1) The method of claim 1 wherein said red blood cells are directly tagged with magnetic particles. ### Claim 5 (depends on 1) The method of claim 1 wherein the wash fluid comprises an anti-species globulin. ### Claim 6 (depends on 5) The method according to claim 5 wherein the anti-species globulin is Coombs serum. ### Claim 7 (depends on 1) The method according to claim 1 wherein a major crossmatch is performed, the sample is patient serum and the magnetic particle red blood cells are from a donor. ### Claim 8 (depends on 1) The method of claim 1 wherein a minor crossmatch is performed, the sample is donor plasma or serum and the magnetic label reactant is patient red blood cells. ### Claim 9 (depends on 1) The method according to claim 1 wherein said method is for antibody screening wherein the sample comprises unknown antibodies and the magnetic labeled particle is reagent red blood cells of known antigens. ### Claim 10 (depends on 1) The method according to claim 1 wherein said method is for forward typing the sample is a reagent of known antibody and the magnetic labeled reagent is of red blood cells with unknown antigens. ### Claim 11 (depends on 1) The method of claim 1 wherein said method is for reverse typing the sample is serum with unknown antibody and the magnetic labeled particle is reagent red blood cells of known antigens. ### Claim 12 (depends on 1) The method according to claim 1 wherein the method is for performing an indirect Coombs, the sample is patient serum, the magnetic labeled particles are reagent group O red blood cells. ### Claim 13 (depends on 1) The method according to claim 1 wherein the method is for a direct Coombs test, the sample is patient's red blood cells in its own serum or plasma and the magnetic labeled particle is patient's red blood cells. ### Claim 14 (depends on 1) The method of claim 1 wherein the paramagnetic capture element has anti-human globulin deposited thereon. ### Claim 15 (depends on 1) The method of claim 1 wherein the wash fluid comprises anti-human globulin. ### Claim 16 (depends on 1) The method of claim 1 wherein the paramagnetic element is fixed in the capture vessel. ### Claim 17 (depends on 1) The method of claim 1 wherein the paramagnetic element is freely movable in the capture vessel. ### Claim 18 (depends on 1) The method of claim 1 wherein the paramagnetic element is semi-fixed in the capture vessel and comprises a movable portion. ### Claim 19 (depends on 1) The method of claim 1 wherein the magnetic pull is in a downward direction. ### Claim 20 (depends on 1) The method of claim 1 wherein the paramagnetic element is of spherical shape and comprises protuberances thereon.